Eva Hellmis
Impact in
- Urology top 5%
- Urinary Bladder and Prostate Research
- Biochemistry top 10%
- Antioxidant Activity and Oxidative Stress
- Phytochemicals and Antioxidant Activities
Papers in
-
- Prostate Cancer Treatment and Research 11
- Renal cell carcinoma treatment 1
- Oncology 4
- PARP inhibition in cancer therapy 3
- Cancer Immunotherapy and Biomarkers 1
- Co-authors
- Günther Heinz Jacobi (1 shared paper)Ute C. Obermüller-Jevic (1 shared paper)Hans Konrad Biesalski (1 shared paper)Boris Alexander Hadaschik (2 shared papers)Daniela Marschall‐Kehrel (1 shared paper)Helmut G. Madersbacher (1 shared paper)Daniela Schultz‐Lampel (1 shared paper)Gerhard J. Strugala (1 shared paper)
- Journals
- Prostate Cancer and Prostatic Diseases (2 papers)Journal of Clinical Oncology (2 papers)European Urology (2 papers)The Lancet (1 paper)Annals of Oncology (1 paper)
- Partner nations
- GermanyUnited StatesCanada
In The Last Decade
Eva Hellmis
17 papers receiving 645 citations
Eva Hellmis's Hit Papers
Peers
Comparison fields: 5 of 53
- Urology 79
- Biochemistry 53
- Pulmonary and Respiratory Medicine 191
- Oncology 130
- Surgery 161
Countries citing papers authored by Eva Hellmis
This map shows the geographic impact of Eva Hellmis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Hellmis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Hellmis more than expected).
Fields of papers citing papers by Eva Hellmis
This network shows the impact of papers produced by Eva Hellmis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Hellmis. The network helps show where Eva Hellmis may publish in the future.
Co-authors
The 25 scholars most cited alongside Eva Hellmis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer Hit paper breakdown → | 2023 | 248 |
| 2 | 2008 | 129 | |
| 3 | 2020 | 103 | |
| 4 | 2023 | 53 | |
| 5 | 2009 | 48 | |
| 6 | 2008 | 25 | |
| 7 | Durvalumab in combination with BCG for BCG-naive, high-risk, non-muscle-invasive bladder cancer (POTOMAC): final analysis of a randomised, open-label, phase 3 trial Hit paper breakdown → | 2025 | 18 |
| 8 | 2022 | 10 | |
| 9 | 2022 | 9 | |
| 10 | 2021 | 4 | |
| 11 | 2021 | 3 | |
| 12 | 2023 | 3 | |
| 13 | 2025 | 3 | |
| 14 | 2025 | 2 | |
| 15 | 2021 | 1 | |
| 16 | 2022 | 1 | |
| 17 | 2025 | 1 | |
| 18 | 2026 | 0 |
About Eva Hellmis
Eva Hellmis is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Urology, Surgery and Biochemistry, having authored 18 papers that have together received 661 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (11 papers), Bladder and Urothelial Cancer Treatments (4 papers), PARP inhibition in cancer therapy (3 papers), Urinary Bladder and Prostate Research (2 papers), Cancer Immunotherapy and Biomarkers (1 paper), Antioxidant Activity and Oxidative Stress (1 paper), Sexual function and dysfunction studies (1 paper) and Renal cell carcinoma treatment (1 paper). The work is most often cited by research in Urology (79 citations), Biochemistry (53 citations), Pulmonary and Respiratory Medicine (191 citations), Oncology (130 citations) and Surgery (161 citations). Eva Hellmis has collaborated with scholars based in Germany, United States and Canada. Frequent co-authors include Günther Heinz Jacobi, Ute C. Obermüller-Jevic, Hans Konrad Biesalski, Boris Alexander Hadaschik, Daniela Marschall‐Kehrel, Helmut G. Madersbacher, Daniela Schultz‐Lampel, Gerhard J. Strugala, P.R. Bock and Saladin Helmut Alloussi. Their work appears in journals such as Prostate Cancer and Prostatic Diseases, Journal of Clinical Oncology, European Urology, The Lancet and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.